First Time Loading...
A

Alliance Pharma PLC
LSE:APH

Watchlist Manager
Alliance Pharma PLC
LSE:APH
Watchlist
Price: 33.1 GBX -1.78% Market Closed
Updated: May 5, 2024

Alliance Pharma PLC
Revenue

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Alliance Pharma PLC
Revenue Peer Comparison

Comparables:
GSK
AZN
INDV
HIK
DPH

Competitive Revenue Analysis
Latest Figures & CAGR of Competitors

Company Revenue CAGR 3Y CAGR 5Y CAGR 10Y
A
Alliance Pharma PLC
LSE:APH
Revenue
£170m
CAGR 3-Years
9%
CAGR 5-Years
10%
CAGR 10-Years
14%
GlaxoSmithKline PLC
LSE:GSK
Revenue
£30.3B
CAGR 3-Years
8%
CAGR 5-Years
0%
CAGR 10-Years
2%
AstraZeneca PLC
LSE:AZN
Revenue
$45.8B
CAGR 3-Years
20%
CAGR 5-Years
16%
CAGR 10-Years
6%
Indivior PLC
LSE:INDV
Revenue
$1.1B
CAGR 3-Years
19%
CAGR 5-Years
2%
CAGR 10-Years
N/A
Hikma Pharmaceuticals PLC
LSE:HIK
Revenue
$2.9B
CAGR 3-Years
7%
CAGR 5-Years
7%
CAGR 10-Years
8%
Dechra Pharmaceuticals PLC
LSE:DPH
Revenue
£761.5m
CAGR 3-Years
14%
CAGR 5-Years
13%
CAGR 10-Years
15%

See Also

What is Alliance Pharma PLC's Revenue?
Revenue
170m GBP

Based on the financial report for Jun 30, 2023, Alliance Pharma PLC's Revenue amounts to 170m GBP.

What is Alliance Pharma PLC's Revenue growth rate?
Revenue CAGR 10Y
14%

Over the last year, the Revenue growth was 4%. The average annual Revenue growth rates for Alliance Pharma PLC have been 9% over the past three years , 10% over the past five years , and 14% over the past ten years .